AstraZeneca Said to Have Explored Bristol Myers Merger
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
By Dinesh Nair, Michelle F. Davis, Ashleigh Furlong and Kelly Gilblom · Bloomberg Markets
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.